ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,122.50
0.54%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Gritstone bio Inc (GRTS)

  7. Gritstone bio Inc (GRTS) Noticias

GRTS Gritstone bio Inc

0.80
-0.1728 (-17.76%)
10 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Gritstone bio Inc GRTS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.1728 -17.76% 0.80 18:58:40
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.8501 0.7821 0.8712 0.7845 0.9728
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/5/202415:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202415:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:07EDGAR2Form 8-K - Current report
09/5/202415:05GLOBEGritstone bio Reports First Quarter 2024 Financial Results..
02/5/202415:05GLOBEGritstone bio to Report First Quarter 2024 Financial Results..
30/4/202406:00GLOBEGritstone bio Highlights the Durability and Potential Broad..
29/4/202406:00GLOBEGritstone bio Announces Appointment of Stephen Webster to..
15/4/202406:00GLOBENature Medicine Publishes Interim Results from Gritstone..
08/4/202407:00GLOBEGritstone bio to Participate in Upcoming Investor and..
08/4/202406:00GLOBEGritstone bio Presents Improvements to EDGE™ Platform at..
01/4/202422:00GLOBEGritstone bio Announces Pricing of $32.5 Million..
01/4/202415:10GLOBEGritstone bio Announces Proposed Public Offering
01/4/202415:01GLOBEGritstone bio Announces Positive Preliminary..
05/3/202415:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202415:08EDGAR2Form 8-K - Current report
05/3/202415:05GLOBEGritstone bio Reports Fourth Quarter and Full Year 2023..
29/2/202415:05GLOBEGritstone bio Announces Workforce Reduction 
21/2/202406:00GLOBEGritstone bio to Participate in Upcoming Investor and..
13/2/202411:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202406:39EDGAR2Form 8-K - Current report
12/2/202406:00GLOBEGritstone bio Announces Update to Comparative Phase 2b..
08/2/202415:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
05/2/202418:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202418:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202418:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202406:00GLOBEGritstone bio to Participate in Upcoming Investor Conference
10/1/202415:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
01/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
22/12/202315:06EDGAR2Form S-3 - Registration statement under Securities Act of..
07/12/202315:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
20/11/202306:00GLOBEGritstone bio to Participate in Upcoming Investor..
08/11/202315:06EDGAR2Form 8-K - Current report
08/11/202315:05GLOBEGritstone bio Reports Third Quarter 2023 Financial Results..
07/11/202315:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
12/10/202316:00GLOBEGenevant Sciences LNP Technology Used in samRNA Covid-19..
11/10/202306:10GLOBEPresentations at IDWeek 2023 Highlight Potentially..
10/10/202306:00GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
04/10/202315:05GLOBEGritstone bio Announces Presentations from Phase 1 Studies..
27/9/202315:07EDGAR2Form 8-K - Current report
27/9/202315:01GLOBEGritstone bio Awarded BARDA Contract to Conduct Comparative..
13/9/202315:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
05/9/202306:00GLOBEGritstone bio to Participate in Upcoming Investor..
16/8/202315:30GLOBEGritstone bio Announces Inducement Grants Under Nasdaq..
15/8/202306:21EDGAR2Form 8-K - Current report
15/8/202306:00GLOBEGritstone bio and Genevant Sciences Announce Option and..
09/8/202315:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:08EDGAR2Form 8-K - Current report
09/8/202315:05GLOBEGritstone bio Reports Second Quarter 2023 Financial Results..

Su Consulta Reciente

NASDAQ
GRTS
Gritstone bio
BOV
LTEL3B
Litel Participacoes ON
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados